Emergent BioSolutions Inc. has announced that the FDA has fast-tracked their application for an over-the-counter (OTC) version of their trademarked Narcan nasal spray, and are anticipating approval as early as March 29th, 2023. A week prior, FDA Commissioner Robert Califf issued an open call for such applications, promising to assign
Naloxone Access Update: Over-the-counter Narcan expected in March, 2023
